Anti-infective Ceftazidime / Sulbactam Combined Formulation is a dose that is formulated in the ratio of 2:1. The Anti-infective Combined Formulation contains Ceftazidime is a third generation cephalosporin and has broad spectrum of coverage and Sulbactam is an irreversible inhibitor of beta-lactamase. The Anti-infective Combined Formulation is used to increase efficacy, to reduce the resistance, side-effects and offers a better choice when compared with multi-drug regimen therapies. Anti-infective Ceftazidime / Sulbactam Combined Formulation is indicated for the treating infections of immuno-compromised patients [burns, cancer, AIDS], serious ICU infections, lower respiratory tract infections and many other infections
